VTCN1 and neoplasm: B7-H4 knockdown increased CD8+ T cell–mediated cytotoxicity in vitro, suggesting that B7-H4 expression may shield tumors from immune surveillance by suppressing the tumor-infiltrating CD8+ T lymphocytes in the tumor microenvironment [23, 28].